Equities

Dr Martens PLC

DOCS:LSE

Dr Martens PLC

Consumer DiscretionaryPersonal Goods
  • Price (GBX)67.35
  • Today's Change0.05 / 0.07%
  • Shares traded2.35m
  • 1 Year change-10.02%
  • Beta0.5677
Data delayed at least 20 minutes, as of Feb 06 2026 16:35 GMT.
More ▼

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Dr Martens PLC's revenues fell -10.20% from 877.10m to 787.60m. This along with an increase in selling, general and administrative costs has contributed to a reduction in net income from 69.20m to 4.50m, a -93.50% decrease.
Gross margin65.52%
Net profit margin1.95%
Operating margin6.83%
Return on assets1.70%
Return on equity4.61%
Return on investment2.15%
More ▼

Cash flow in GBPView more

In 2025, Dr Martens PLC increased its cash reserves by 40.32%, or 44.80m. The company earned 196.30m from its operations for a Cash Flow Margin of 24.92%. In addition the company used 15.30m on investing activities and also paid 134.20m in financing cash flows.
Cash flow per share0.0854
Price/Cash flow per share7.62
Book value per share0.3405
Tangible book value per share0.058
More ▼

Balance sheet in GBPView more

Dr Martens PLC has a Debt to Total Capital ratio of 54.54%, a lower figure than the previous year's 118.95%.
Current ratio2.18
Quick ratio1.08
Total debt/total equity1.20
Total debt/total capital0.5454
More ▼

Growth rates in GBP

Year on year, growth in dividends per share remained flat while earnings per share excluding extraordinary items fell by -93.42%. Additionally, five year annualized earnings per share growth ranks highest in its industry.
Div yield(5 year avg)--
Div growth rate (5 year)--
Payout ratio (TTM)160.78%
EPS growth(5 years)-42.70
EPS (TTM) vs
TTM 1 year ago		-48.89
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.